Hosted on MSN16d
Senseera secures $7.1m in funding to advance liquid biopsy platform
Senseera has closed a seed funding round, securing $7.1m to further develop its GEM BIOMARKERS liquid biopsy platform. Lightspeed Venture Partners led the financing round, with contributions from the ...
Morningstar17d
Senseera Raises $7.1 Million Seed Round Led by Lightspeed Venture Partners
JERUSALEM, Jan. 7, 2025 /PRNewswire/ -- Senseera, a liquid biopsy company pioneering chromatin epigenomics, announced the successful close of a $7.1 million seed funding round led by Lightspeed ...
Yahoo Finance17d
Senseera Raises $7.1 Million Seed Round Led by Lightspeed Venture Partners
The funding will advance Senseera's GEM BIOMARKERS™ liquid biopsy platform, powered by cfChIP-seq technology. The platform decodes cell-specific gene expression and cell states from a simple ...
Yahoo Finance17d
Senseera Raises $7.1 Million Seed Round Led by Lightspeed Venture Partners
The funding will advance Senseera's GEM BIOMARKERS™ liquid biopsy platform, powered by cfChIP-seq technology. The platform decodes cell-specific gene expression and cell states from a simple blood ...